How virtual reality is changing the game for Alzheimer's disease

For most people, putting on virtual reality (VR) goggles means entering a video game. But for Dr. Manu Madhav, a CLEAR-funded neuroscientist at the University of British Columbia, it’s a gateway to the future of Alzheimer’s research, where immersive technology may help detect the disease earlier and more accurately than ever before.

---

A new frontier in early detection

Early detection of Alzheimer’s disease and other dementias can have a significant impact on quality of life,” says Dr. Madhav. “Lifestyle changes and medications can slow disease progression, but current diagnostic methods rely on expensive and invasive biomarker testing.”

That’s where VR could revolutionize the field. Dr. Madhav and a growing community of cognitive neuroscientists are using virtual environments to measure subtle impairments in spatial memory and navigation, two brain functions known to deteriorate in the earliest stages of Alzheimer’s disease.

---

Turning research into real-world impact

As part of the Cognitive Neuroscience Society (CNS) 2025 Annual Meeting in Boston, researchers presented breakthrough findings showing how participants (including healthy older adults, those with mild cognitive impairment, and early Alzheimer’s patients) perform differently when navigating 3D virtual environments.

By integrating VR with brain and blood biomarkers, scientists are uncovering how the buildup of Alzheimer’s-related proteins like amyloid-beta and tau correlate with changes in spatial awareness, even before traditional symptoms appear.

Dr. Madhav’s background in engineering and robotics gives his team a unique edge in designing these virtual spaces. “We’ve worked hard to make VR comfortable and intuitive for older participants,” he explains. “Our systems now allow individuals to explore immersive environments for over an hour with minimal nausea or disorientation.”

Using head and eye tracking sensors and controller-based input, participants navigate corridors, locate hidden landmarks, and track their position, activities that mimic real-world spatial navigation. Early data has already revealed differences in how young and older adults perform these tasks, paving the way for trials involving people diagnosed with early Alzheimer’s disease later this year.

---

A promising path forward

By transforming a technology once reserved for entertainment into a clinical research tool, Dr. Madhav and his colleagues are pushing the boundaries of how we study (and one day may treat) Alzheimer’s disease.

“The recent increase in accessibility to VR systems means more labs can now join this work,” says Dr. Madhav. “We’re entering a new era where immersive technology can help answer complex cognitive questions and, potentially, improve early diagnosis for millions.”

Read the full article by the Cognitive Neuroscience Society, by clicking here.